Zetta Medical Technologies has received clearance from the U.S. Food and Drug Administration (FDA) to market its Zia iterative reconstruction software designed for low-dose CT protocols.
The vendor-neutral software is compatible with CT equipment from the major manufacturers, Zetta said. It utilizes the DICOM communications protocol to receive low-dose images, which are then processed, and enhanced images are automatically transferred to a PACS.
Zetta is an independent service organization (ISO) that provides products, service, and sales for CT, MRI, and PET/CT equipment.
